Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 20mg | $200.00$106.00 | $5.30/mg | In stock | Jul 8 |
| vial | 50mg | $400.00$244.00 | $4.88/mg | In stock | Jul 8 |
| vial | 100mg | $540.00$450.00 | $4.50/mg | In stock | Jul 8 |
| vial | 200mg | $1080.00$780.00 | $3.90/mg | In stock | Jul 8 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| BP20250620 | — | 99.9% | TrustPointe Analytics | Endotoxin | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Peptide Partners sell BPC-157?
Yes — Peptide Partners currently lists BPC-157 in 4 variants starting at $780.00 ($3.90/mg).
Is Peptide Partners's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 5 Certificates of Analysis for Peptide Partners's BPC-157, with the most recent showing 99.9% purity. Peptide Partners holds an overall trust grade of A (91/100) across all 106 COAs on file.
What is Peptide Partners's trust grade for BPC-157?
Peptide Partners has an overall Disclosed Labs trust grade of A (91/100), computed from 106 COAs across all peptides. The most recent BPC-157 COA was issued by TrustPointe Analytics.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $1.82/mg — compare with Peptide Partners's listing at $3.90/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BP20250808 | — | 100.0% | TrustPointe Analytics | Endotoxin, Heavy metals | Confirmed | View |
| BP202512 | — | 99.5% | TrustPointe Analytics | Endotoxin, Heavy metals | Confirmed | View |
| BC202607 | — | 99.7% | Kovera Labs | Endotoxin, Sterility, Heavy metals | Unverified | View |
| BC202604 | — | 99.8% | TrustPointe Analytics | Endotoxin, Heavy metals | Confirmed | View |
Disclosed Labs